The prognostic value of brain MRI in clinically isolated syndromes of the CNS. A 10-year follow-up.

A definitive diagnosis of multiple sclerosis cannot be made at presentation on patients with a clinically isolated syndrome of the optic nerve, spinal cord or brainstem suggestive of demyelination, as dissemination in time is not established. To determine the long-term risk of abnormalities on brain MRI for the development of multiple sclerosis and disability we performed a 10-year follow-up on 81 such patients who had T2-weighted brain MRI at presentation. Initial brain MRI was abnormal in 54 (67%). Follow up of those patients with an abnormal MRI revealed progression to clinically definite multiple sclerosis in 45 out of 54 (83%), of whom 11 (20%) had relapsing/remitting disease (EDSS > 3), 13 (24%) secondary progressive and 21 (39%) benign (relapsing/remitting with EDSS < or = 3) disease. For those with a normal MRI progression to clinically definite multiple sclerosis occurred in only three out of 27 (11%), all benign. There was a significant relationship between the number of lesions at presentation and both EDSS (r = 0.45, P < 0.001) and the type of disease at follow-up (P < 0.0001). Brain MRI at presentation with a clinically isolated syndrome is predictive of the long-term risk of subsequent development of multiple sclerosis, the type of disease and extent of disability.

[1]  W. Bradley,et al.  Acute optic neuritis: prognosis for development of multiple sclerosis. , 1968, Journal of neurology, neurosurgery, and psychiatry.

[2]  H. Lipton,et al.  Acute transverse myelopathy in adults. A follow-up study. , 1973, Archives of neurology.

[3]  W. Mcdonald,et al.  Factors influencing the risk of multiple sclerosis developing in patients with optic neuritis. , 1978, Brain : a journal of neurology.

[4]  P. Wolf,et al.  A prospective study of the risk of developing multiple sclerosis in uncomplicated optic neuritis , 1979, Neurology.

[5]  J. Gilbert,et al.  Unsuspected multiple sclerosis. , 1983, Archives of neurology.

[6]  D. Silberberg,et al.  New diagnostic criteria for multiple sclerosis: Guidelines for research protocols , 1983, Annals of neurology.

[7]  J. Kurtzke.  Rating neurologic impairment in multiple sclerosis , 1983, Neurology.

[8]  P. Landy.  A prospective study of the risk of developing multiple sclerosis in optic neuritis in a tropical and sub-tropical area. , 1983, Journal of neurology, neurosurgery, and psychiatry.

[9]  S. Atlas,et al.  MR diagnosis of acute disseminated encephalomyelitis. , 1986, Journal of computer assisted tomography.

[10]  R. Kakigi,et al.  Disseminated lesions at presentation in patients with optic neuritis. , 1986, Journal of neurology, neurosurgery, and psychiatry.

[11]  D. MacManus,et al.  Magnetic resonance imaging in clinically isolated lesions of the brain stem. , 1986, Journal of neurology, neurosurgery, and psychiatry.

[12]  P. Sandercock,et al.  Magnetic resonance imaging in isolated noncompressive spinal cord syndromes , 1987, Annals of neurology.

[13]  W. Mcdonald,et al.  A reassessment of the risk of multiple sclerosis developing in patients with optic neuritis after extended follow-up. , 1987, Journal of neurology, neurosurgery, and psychiatry.

[14]  J. Rizzo,et al.  Risk of developing multiple sclerosis after uncomplicated optic neuritis , 1988, Neurology.

[15]  A. A. Eisen,et al.  MRI in the diagnosis of MS , 1988, Neurology.

[16]  B E Kendall,et al.  The early risk of multiple sclerosis after optic neuritis. , 1988, Journal of neurology, neurosurgery, and psychiatry.

[17]  J. Oger,et al.  Multiple sclerosis , 1988, Neurology.

[18]  T. Engell.  A clinical patho‐anatomical study of clinically silent multiple sclerosis , 1989, Acta neurologica Scandinavica.

[19]  I. Moseley,et al.  The early risk of multiple sclerosis following isolated acute syndromes of the brainstem and spinal cord , 1989, Annals of neurology.

[20]  I. Moseley,et al.  Acute disseminated encephalomyelitis , 2016, Neurology.

[21]  S. Holtås,et al.  A long‐term prospective study of optic neuritis: Evaluation of risk factors , 1990, Annals of neurology.

[22]  F. Munschauer,et al.  Clinical and magnetic resonance imaging in optic neuritis , 1991, Neurology.

[23]  E. Thompson,et al.  The predictive value of intrathecal immunoglobulin synthesis and magnetic resonance imaging in acute isolated syndromes for subsequent development of multiple sclerosis , 1991, Annals of neurology.

[24]  B. Stigsby,et al.  MRI, VEP, SEP and biothesiometry suggest monosymptomatic acute optic neuritis to be a first manifestation of multiple sclerosis , 1991, Acta neurologica Scandinavica.

[25]  D. Li,et al.  Magnetic resonance imaging of the head in the diagnosis of multiple sclerosis: A prospective 2‐year follow‐up with comparison of clinical evaluation, evoked potentials, oligoclonal banding, and CT , 1991, Neurology.

[26]  G. Comi,et al.  Paraclinical tests in acute‐onset optic neuritis: basal data and results of a short follow‐up , 1991, Acta neurologica Scandinavica.

[27]  B. Ford,et al.  Long‐term follow‐up of acute partial transverse myelopathy , 1992, Neurology.

[28]  A. Thompson,et al.  Serial gadolinium‐enhanced MRI in relapsing/remitting multiple sclerosis of varying disease duration , 1992, Neurology.

[29]  Roland Martin,et al.  Using gadolinium‐enhanced magnetic resonance imaging lesions to monitor disease activity in multiple sclerosis , 1992, Annals of neurology.

[30]  D. Miller,et al.  The significance of brain magnetic resonance imaging abnormalities at presentation with clinically isolated syndromes suggestive of multiple sclerosis. A 5-year follow-up study. , 1993, Brain : a journal of neurology.

[31]  D. Paty,et al.  Interferon beta‐1b is effective in relapsing‐remitting multiple sclerosis , 1993, Neurology.

[32]  A. Thompson,et al.  Spinal cord MRI using multi‐array coils and fast spin echo , 1993, Neurology.

[33]  W. I. McDonald,et al.  Quantitative brain MRI lesion load predicts the course of clinically isolated syndromes suggestive of multiple sclerosis , 1994, Neurology.

[34]  A. Thompson,et al.  Persistent functional deficit in multiple sclerosis and autosomal dominant cerebellar ataxia is associated with axon loss. , 1995, Brain : a journal of neurology.

[35]  H. Tobi,et al.  Correlating MRI and clinical disease activity in multiple sclerosis , 1995, Neurology.

[36]  M. Rovaris,et al.  Acute transverse myelopathy: spinal and cranial MR study with clinical follow-up. , 1995, AJNR. American journal of neuroradiology.

[37]  C. Polman,et al.  The effect of gadolinium on the sensitivity and specificity of MR in the initial diagnosis of multiple sclerosis. , 1995, AJNR. American journal of neuroradiology.

[38]  A J Thompson,et al.  Progressive cerebral atrophy in multiple sclerosis. A serial MRI study. , 1996, Brain : a journal of neurology.

[39]  F. Barkhof,et al.  Guidelines for the use of magnetic resonance techniques in monitoring the treatment of multiple sclerosis , 1996, Annals of neurology.

[40]  A. Thompson,et al.  Spinal cord atrophy and disability in multiple sclerosis. A new reproducible and sensitive MRI method with potential to monitor disease progression. , 1996, Brain : a journal of neurology.

[41]  R. Priore,et al.  Correlation of clinical, magnetic resonance imaging, and cerebrospinal fluid findings in optic neuritis , 1997, Annals of neurology.

[42]  G. Comi,et al.  Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis. , 1997, Brain : a journal of neurology.

[43]  I. Moseley,et al.  Asymptomatic spinal cord lesions in clinically isolated optic nerve, brain stem, and spinal cord syndromes suggestive of demyelination , 1998, Journal of neurology, neurosurgery, and psychiatry.